📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Hepatocellular carcinoma: Prospects for natural killer cell immunotherapy (2018)

First Author: Kumar N

Attributed to: Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/tan.13275

PubMed Identifier: 29667374

Publication URI: http://europepmc.org/abstract/MED/29667374

Type: Journal Article/Review

Parent Publication: HLA

Issue: 1

ISSN: 2059-2302